FNDX up 70% since IPO FendX Technologies (Ticker: FNDX.c) is currently trading 4% up on the TSXV, putting it up 70% since it went public on March 20th.
This newly listed company is creating new solutions to help prevent the spread of pathogens with its proprietary nanotechnology.
FNDX's flagship product is REPELWRAP™, a surface coating that uses nanotech to repel bacteria and viruses to prevent their transmission via surfaces.
REPELWRAP™ film can adhere to a variety of surfaces and is therefore expected to be valuable in a range of environments, particularly in healthcare settings. FNDX intends to bring its REPELWRAP™ film to the Canadian market in 2024.
With this innovative product, FNDX is positioning itself to seize a share of the growing surface coating market which is expected to increase from $1.3 billion in 2020 to $3.5 billion by 2025.
As a step toward commercialization, FNDX recently contracted Dunmore International Corp. to use its engineering expertise to scale up REPELWRAP™ film for testing. This should also help FNDX create larger prototypes and evaluate an automated manufacturing method down the line.
On April 25, FNDX's President and CEO, Dr. Carolyn Myers, is scheduled to participate in the Bloom Burton & Co. Healthcare Investor Conference at the Metro Toronto Convention Centre (North Building). Investors in Toronto are encouraged to attend and meet Dr. Myers. More on FNDX's attendance at the conference can be found here: https://www.newsfilecorp.com/release/162167/FendX-Announces-Upcoming-Conference-Attendance-and-Enters-into-an-IR-Agreement
And if you can't attend the conference, you can still learn all about FNDX and its offerings on the company's website: https://fendxtech.com/ Posted on behalf of FendX Technologies Inc.